These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

26 related articles for article (PubMed ID: 10533805)

  • 1. The relationship of expression of bcl-2, p53, and proliferating cell nuclear antigen (PCNA) to cell proliferation and apoptosis in renal cell carcinoma.
    Zhu Z; Xing S; Cheng P; Li G; Yang Y; Zeng F; Lu G
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(4):354-7. PubMed ID: 15587397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of TP53, BCL-2, and VEGFA Genes in Esophagus Carcinoma and its Biological Significance.
    Wei W; Wang Y; Yu X; Ye L; Jiang Y; Cheng Y
    Med Sci Monit; 2015 Oct; 21():3016-22. PubMed ID: 26439224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of peritumoral tissue analysis in predicting characteristics of hepatocellular carcinoma using ultrasound-based radiomics.
    Qian H; Huang Y; Xu L; Fu H; Lu B
    Sci Rep; 2024 May; 14(1):11538. PubMed ID: 38773179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Lysine Acridone Acetate on the Level of Apoptosis and Expression of Apoptosis-Associated Proteins during Antioncogenic Therapy in Colorectal Cancer in Mice.
    Kozlov AA; Sokolova YO; Kovalenko AL; Bazhanova ED
    Bull Exp Biol Med; 2023 Dec; 176(2):210-215. PubMed ID: 38194065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel aspects of the liver microenvironment in hepatocellular carcinoma pathogenesis and development.
    Tu T; Budzinska MA; Maczurek AE; Cheng R; Di Bartolomeo A; Warner FJ; McCaughan GW; McLennan SV; Shackel NA
    Int J Mol Sci; 2014 May; 15(6):9422-58. PubMed ID: 24871369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of TP53 expression for patients with hepatocellular carcinoma: a meta-analysis.
    Zhan P; Ji YN
    Hepatobiliary Surg Nutr; 2014 Feb; 3(1):11-7. PubMed ID: 24696834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TP53 immunohistochemical expression is associated with the poor outcome for hepatocellular carcinoma: evidence from a meta-analysis.
    Ji YN; Wang Q; Xue J
    Tumour Biol; 2014 Feb; 35(2):1653-9. PubMed ID: 24078450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alterations of TP53 are associated with a poor outcome for patients with hepatocellular carcinoma: evidence from a systematic review and meta-analysis.
    Liu J; Ma Q; Zhang M; Wang X; Zhang D; Li W; Wang F; Wu E
    Eur J Cancer; 2012 Oct; 48(15):2328-38. PubMed ID: 22459764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iron-dependent regulation of MDM2 influences p53 activity and hepatic carcinogenesis.
    Dongiovanni P; Fracanzani AL; Cairo G; Megazzini CP; Gatti S; Rametta R; Fargion S; Valenti L
    Am J Pathol; 2010 Feb; 176(2):1006-17. PubMed ID: 20019189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of survivin, caspase-3, and VEGF expression in thyroid carcinoma.
    Zhang HY; Meng X; Du ZX; Fang CQ; Liu GL; Wang HQ; Deng WW
    Clin Exp Med; 2009 Sep; 9(3):207-13. PubMed ID: 19205619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of Src and FAK in hepatocellular carcinoma and the effect of Src inhibitors on hepatocellular carcinoma in vitro.
    Lau GM; Lau GM; Yu GL; Gelman IH; Gutowski A; Hangauer D; Fang JW
    Dig Dis Sci; 2009 Jul; 54(7):1465-74. PubMed ID: 18979199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathological characteristics, PCNA labeling index and DNA index in prognostic evaluation of patients with moderately differentiated hepatocellular carcinoma.
    Zeng WJ; Liu GY; Xu J; Zhou XD; Zhang YE; Zhang N
    World J Gastroenterol; 2002 Dec; 8(6):1040-4. PubMed ID: 12439921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of p53 on apoptosis and proliferation of hepatocellular carcinoma cells treated with transcatheter arterial chemoembolization.
    Xiao EH; Li JQ; Huang JF
    World J Gastroenterol; 2004 Jan; 10(2):190-4. PubMed ID: 14716820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C; Dragnea A; Ivanov B; Pechianu C; Herlea V; Sgarbura O; Popescu A; Popescu I
    J Gastrointestin Liver Dis; 2008 Dec; 17(4):411-7. PubMed ID: 19104702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of p53 and bcl-2 proteins to apoptosis and cell proliferation in liver cirrhosis and hepatocellular carcinoma].
    Feng D; Zheng H; Shen M; Cheng R; Yan Y
    Hunan Yi Ke Da Xue Xue Bao; 1999; 24(4):325-8. PubMed ID: 12080637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA fragmentation and cell proliferation correlated with tumor grade in patients with hepatocellular carcinoma.
    Kalogeraki A; Garbagnati F; Santinami M; Zoras O
    Cancer; 2002 Oct; 96(5):301-5. PubMed ID: 12378598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatocellular proliferation and development of hepatocellular carcinoma: a case-control study in chronic hepatitis C.
    Dutta U; Kench J; Byth K; Khan MH; Lin R; Liddle C; Farrell GC
    Hum Pathol; 1998 Nov; 29(11):1279-84. PubMed ID: 9824107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance between cell proliferation and cellular DNA fragmentation in hepatocellular carcinoma.
    Wu PC; Lau VK; Fang JW; Lai VC; Lai CL; Lau JY
    Liver; 1999 Oct; 19(5):444-51. PubMed ID: 10533805
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.